Log in
(Ad)
If you're happy with stocks yielding you 4% or 5% a year, you don't need this. But if you want to see how we built a portfolio that now pays us a 67% cash on cash return - with no leverage, options, or gimmicks.

NYSE:ALB - Albemarle Stock Price, Forecast & News

$81.90
+0.52 (+0.64 %)
(As of 01/24/2020 03:26 AM ET)
Today's Range
$79.51
Now: $81.90
$82.10
50-Day Range
$63.77
MA: $72.05
$81.90
52-Week Range
$58.63
Now: $81.90
$93.14
Volume1.65 million shs
Average Volume2.05 million shs
Market Capitalization$8.68 billion
P/E Ratio15.22
Dividend Yield1.81%
Beta1.67
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. Read More…

Industry, Sector and Symbol

Industry Plastics materials & resins
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
CUSIP01265310
Phone980-299-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.37 billion
Cash Flow$7.60 per share
Book Value$35.40 per share

Profitability

Net Income$693.56 million

Miscellaneous

Employees5,900
Market Cap$8.68 billion
Next Earnings Date2/19/2020 (Confirmed)
OptionableOptionable

Receive ALB News and Ratings via Email

Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

A U.S. congressional committee passed important legislation that enables each state to set its own policies around cannabis… This bill also allows states to expunge federal marijuana convictions and arrests. This will likely lead to federal legalization sooner than expected. Get in early and you just might be the next 'Marijuana Millionaire'...

Albemarle (NYSE:ALB) Frequently Asked Questions

What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle announced a quarterly dividend on Tuesday, October 29th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.368 per share on Thursday, January 2nd. This represents a $1.47 dividend on an annualized basis and a yield of 1.80%. The ex-dividend date of this dividend is Thursday, December 12th. This is an increase from Albemarle's previous quarterly dividend of $0.37. View Albemarle's Dividend History.

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) released its quarterly earnings results on Wednesday, November, 6th. The specialty chemicals company reported $1.53 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.49 by $0.04. The specialty chemicals company earned $879.70 million during the quarter, compared to the consensus estimate of $883.67 million. Albemarle had a return on equity of 15.94% and a net margin of 16.27%. The business's revenue was up 13.1% compared to the same quarter last year. During the same period last year, the firm posted $1.31 earnings per share. View Albemarle's Earnings History.

When is Albemarle's next earnings date?

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Albemarle.

How can I listen to Albemarle's earnings call?

Albemarle will be holding an earnings conference call on Wednesday, February 19th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle updated its FY 2024 Pre-Market earnings guidance on Thursday, December, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $4.4-5 billion.

What price target have analysts set for ALB?

23 equities research analysts have issued 12-month target prices for Albemarle's stock. Their forecasts range from $39.50 to $128.00. On average, they anticipate Albemarle's stock price to reach $79.84 in the next twelve months. This suggests that the stock has a possible downside of 2.5%. View Analyst Price Targets for Albemarle.

What is the consensus analysts' recommendation for Albemarle?

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 4 sell ratings, 9 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Albemarle.

Has Albemarle been receiving favorable news coverage?

News coverage about ALB stock has been trending extremely negative this week, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Albemarle earned a daily sentiment score of -5.0 on InfoTrie's scale. They also gave media stories about the specialty chemicals company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Albemarle.

Who are some of Albemarle's key competitors?

What other stocks do shareholders of Albemarle own?

Who are Albemarle's key executives?

Albemarle's management team includes the folowing people:
  • Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 54)
  • Mr. Scott A. Tozier, Exec. VP & CFO (Age 53)
  • Mr. Donald J. LaBauve Jr., VP, Corp. Controller & Chief Accounting Officer (Age 52)
  • Ms. Karen G. Narwold, Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 59)
  • Mr. David Ryan, VP of Corp. Strategy & Investor Relations

Who are Albemarle's major shareholders?

Albemarle's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include SPF Beheer BV (1.05%), KAMES CAPITAL plc (0.69%), Commerzbank Aktiengesellschaft FI (0.34%), Hahn Capital Management LLC (0.18%), Zurcher Kantonalbank Zurich Cantonalbank (0.18%) and Professional Advisory Services Inc. (0.13%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View Institutional Ownership Trends for Albemarle.

Which major investors are selling Albemarle stock?

ALB stock was sold by a variety of institutional investors in the last quarter, including Janney Capital Management LLC, Leavell Investment Management Inc., IFP Advisors Inc, Zurcher Kantonalbank Zurich Cantonalbank, Hahn Capital Management LLC, SFE Investment Counsel, AE Wealth Management LLC and State of Alaska Department of Revenue. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View Insider Buying and Selling for Albemarle.

Which major investors are buying Albemarle stock?

ALB stock was purchased by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, SPF Beheer BV, Deane Retirement Strategies Inc., Tocqueville Asset Management L.P., OLD Second National Bank of Aurora, Mission Wealth Management LP, Kempner Capital Management Inc. and Red Spruce Capital LLC. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow and Eric Norris. View Insider Buying and Selling for Albemarle.

How do I buy shares of Albemarle?

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $81.90.

How big of a company is Albemarle?

Albemarle has a market capitalization of $8.68 billion and generates $3.37 billion in revenue each year. The specialty chemicals company earns $693.56 million in net income (profit) each year or $5.48 on an earnings per share basis. Albemarle employs 5,900 workers across the globe.View Additional Information About Albemarle.

What is Albemarle's official website?

The official website for Albemarle is http://www.albemarle.com/.

How can I contact Albemarle?

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]


MarketBeat Community Rating for Albemarle (NYSE ALB)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  653 (Vote Outperform)
Underperform Votes:  537 (Vote Underperform)
Total Votes:  1,190
MarketBeat's community ratings are surveys of what our community members think about Albemarle and other stocks. Vote "Outperform" if you believe ALB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel